Chloroquine–Primaquine Therapeutic Efficacy, Safety, and Plasma Levels in Patients with Uncomplicated Plasmodium vivax Malaria in a Colombian Pacific Region
The DOI matches its Crossref record.
Abstract
In Colombia, published studies for the treatment of uncomplicated Plasmodium vivax malaria with chloroquine–primaquine (CQ-PQ) are scarce. The aim of the study was to evaluate the therapeutic efficacy and safety profile of this combination. A clinical trial was performed in adults with uncomplicated P. vivax malaria using the 28-day World Health Organization validated protocol. Patients received supervised antimalarial treatment and the primary efficacy end point was the clinical and parasitological response. Safety was assessed through adverse events surveillance, and plasma levels of antimalarial drugs were measured. A total of 77 patients were included. Adequate clinical and parasitological response rate diagnosed by thick blood smear examination was achieved in 72 of 73 patients (98.6%) with a complete 28-day follow-up. There were two parasitological therapeutic failures (TFs) (2.9%) on day 28, established by polymerase chain reaction among 68 patients, one of them with a positive film. No adverse events were detected. After completing the antimalarial treatment, all patients reached adequate plasma concentrations of CQ and desethylchloroquine (DECQ), with medians of 302.9 and 104.0 ng/mL, respectively. Uncomplicated P. vivax malaria treatment with CQ–PQ standard treatment was effective and safe in the study population; TFs were not associated with low plasma levels of CQ and DECQ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the therapeutic success on day 28 is lower than studies in Southwestern India (100%), Central China (100%), Brazil (100%), and Colombia (98.6%) [27–30], as well as two Ethiopian studies (Arbamich 100%, Bishoftu-Adama 99.2%) [31, 32], the day 42 success rate in this study is comparable to findings from Arbamich [31] but lower than those from India (100%) and China (96.1%) [33, 34].”
In the citing paper
“In this study, no severe adverse events were reported, and the treatment was safe and well-tolerated, consistent with studies conducted in Colombia [28].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 4
- Ríos, 2013, Diez años de eficacia terapéutica de la cloroquina en malaria no complicada por Plasmodium vivax, Turbo, Antioquia, años 2002 y 2011, 33, 429
- Pérez, 2008, Eficacia de la combinación amodiaquina más sulfadoxina pirimetamina y de la cloroquina para el tratamiento del paludismo en Córdoba, Colombia, 2006, 28, 148
- Blair, 2002, Adecuada respuesta clínica y parasitológica de Plasmodium vivax a la cloroquina en Colombia (Turbo, Antioquia), 2001, 6, 21
- Commons, 2018, The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis, 18, 1025
Cited by
Getu, E., Biruksew, A., Eshetu, T., Abamecha, A., Assefa, D. G., Mohammed, H., Wuletaw, Y., Tasew, G., Tollera, G., Hailu, M., et al. (2025) · Malaria Journal · doi:10.1186/s12936-025-05446-y · Cited by 4
Metadata
- Authors
- Mesa-Echeverry, E., Niebles-Bolívar, M., & Tobón-Castaño, A.
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2019-01-09
- Volume
- 100
- Issue
- 1
- Pages
- 72-77
- ISSN
- 0002-9637
- 1476-1645
- Cited by
- 15
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.